Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia

Alfonso Zaccaria, Anna Maria Valenti, Emilio Donti, Alessandro Gozzetti, Sonia Ronconi, Francesco Spedicato

Research output: Contribution to journalArticle

Abstract

Five Philadelphia chromosome positive (Ph) chronic myeloid leukemia (CML) patients with additional chromosome abnormalities at diagnosis have been followed during Imatinib therapy. In all, the Ph chromosome disappeared, while the 5 cases, additional abnormalities [dup(1); del(5), +8 (2 patients) and +14] persisted in the subsequent studies, performed over a period of 11 to 49 months, either alone or together with a karyotypically normal cell population. This finding is consistent with a secondary origin of the Ph chromosome in these patients. It is still to early to evaluate the possible prognostic value of these additional abnormalities.

Original languageEnglish
Pages (from-to)564-565
Number of pages2
JournalHaematologica
Volume92
Issue number4
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Philadelphia Chromosome
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Chromosome Aberrations
Chromosomes
Therapeutics
Population
Imatinib Mesylate

Keywords

  • Additional abnormalities
  • Imatinib resistance
  • Pathogenesis
  • Ph

ASJC Scopus subject areas

  • Hematology

Cite this

Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia. / Zaccaria, Alfonso; Valenti, Anna Maria; Donti, Emilio; Gozzetti, Alessandro; Ronconi, Sonia; Spedicato, Francesco.

In: Haematologica, Vol. 92, No. 4, 04.2007, p. 564-565.

Research output: Contribution to journalArticle

Zaccaria, Alfonso ; Valenti, Anna Maria ; Donti, Emilio ; Gozzetti, Alessandro ; Ronconi, Sonia ; Spedicato, Francesco. / Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia. In: Haematologica. 2007 ; Vol. 92, No. 4. pp. 564-565.
@article{ec2a352c961c49c1a77447e0bffa6d4d,
title = "Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia",
abstract = "Five Philadelphia chromosome positive (Ph) chronic myeloid leukemia (CML) patients with additional chromosome abnormalities at diagnosis have been followed during Imatinib therapy. In all, the Ph chromosome disappeared, while the 5 cases, additional abnormalities [dup(1); del(5), +8 (2 patients) and +14] persisted in the subsequent studies, performed over a period of 11 to 49 months, either alone or together with a karyotypically normal cell population. This finding is consistent with a secondary origin of the Ph chromosome in these patients. It is still to early to evaluate the possible prognostic value of these additional abnormalities.",
keywords = "Additional abnormalities, Imatinib resistance, Pathogenesis, Ph",
author = "Alfonso Zaccaria and Valenti, {Anna Maria} and Emilio Donti and Alessandro Gozzetti and Sonia Ronconi and Francesco Spedicato",
year = "2007",
month = "4",
doi = "10.3324/haematol.10783",
language = "English",
volume = "92",
pages = "564--565",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "4",

}

TY - JOUR

T1 - Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia

AU - Zaccaria, Alfonso

AU - Valenti, Anna Maria

AU - Donti, Emilio

AU - Gozzetti, Alessandro

AU - Ronconi, Sonia

AU - Spedicato, Francesco

PY - 2007/4

Y1 - 2007/4

N2 - Five Philadelphia chromosome positive (Ph) chronic myeloid leukemia (CML) patients with additional chromosome abnormalities at diagnosis have been followed during Imatinib therapy. In all, the Ph chromosome disappeared, while the 5 cases, additional abnormalities [dup(1); del(5), +8 (2 patients) and +14] persisted in the subsequent studies, performed over a period of 11 to 49 months, either alone or together with a karyotypically normal cell population. This finding is consistent with a secondary origin of the Ph chromosome in these patients. It is still to early to evaluate the possible prognostic value of these additional abnormalities.

AB - Five Philadelphia chromosome positive (Ph) chronic myeloid leukemia (CML) patients with additional chromosome abnormalities at diagnosis have been followed during Imatinib therapy. In all, the Ph chromosome disappeared, while the 5 cases, additional abnormalities [dup(1); del(5), +8 (2 patients) and +14] persisted in the subsequent studies, performed over a period of 11 to 49 months, either alone or together with a karyotypically normal cell population. This finding is consistent with a secondary origin of the Ph chromosome in these patients. It is still to early to evaluate the possible prognostic value of these additional abnormalities.

KW - Additional abnormalities

KW - Imatinib resistance

KW - Pathogenesis

KW - Ph

UR - http://www.scopus.com/inward/record.url?scp=34547691666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547691666&partnerID=8YFLogxK

U2 - 10.3324/haematol.10783

DO - 10.3324/haematol.10783

M3 - Article

C2 - 17488671

AN - SCOPUS:34547691666

VL - 92

SP - 564

EP - 565

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -